Long-Term Outcomes With Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks

home / publications / supplement / long-term-outcomes-with-subcutaneous-c1-inhibitor-replacement-therapy-for-prevention-of-heredita

Long-Term Outcomes With Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks

September 17th 2020
ArticleARTICLES

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo